Concepedia

David Trueman

DT

Statistics

Publications

11

Citations

370

H-Index

11

Active since

1984

Affiliations

Office Of Health Economics(Current)

Novartis (Switzerland)

College of New Jersey

CACI International (United Kingdom)

William Paterson University

David Trueman is an author at Office Of Health Economics specializing in pharmacy, cost-effectiveness analysis, and pharmacotherapy.

ORCID

Publications per year

1984–2022

11

Publications

11

Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction

John J.V. McMurray, David Trueman, Elizabeth Hancock et al. · Heart · 2017 · 72 citations · Full text

, , +17

Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis

Nihar R. Desai, Caresse Campbell, Batul Electricwala et al. · American Journal of Cardiovascular Drugs · 2022 · 47 citations · Full text

, , +17

Depersonalization in a Nonclinical Population

David Trueman · The Journal of Psychology · 1984 · 42 citations

, , +5

Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction

Zanfina Ademi, Alena M. Pfeil, Elizabeth Hancock et al. · Swiss Medical Weekly · 2017 · 36 citations · Full text

, , +17

An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK

Daniel Viriato, Natalie Bennett, Raisa Sidhu et al. · Advances in Therapy · 2020 · 35 citations · Full text

, , +17

1–5 of 11